Importantly, agents targeting tumor necrosis factor-α signaling were effective for EP treatment, suggesting that the pathophysiology of EP and obesity shared some cytokines that are known to contribute to features of the MetS, such as hypertension, dyslipidemia, and insulin resistance (30, 31). Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.